AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

Imaging Technology

JANUARY 30, 2025

30, 2025 Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care Disease 52

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 130

Imaging Technology

JANUARY 14, 2025

8, 2025 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8, Since then, the U.S.

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care PET Scan 52